 Sonnet BioTherapeutics Holdings Inc NASDAQ: SONN priced the underwritten public offering of 35.3 million shares including pre-funded warrants and warrants to purchase up to 35.3 million shares. Each share of common stock or pre-funded warrant has a combined price of 0.85, raising approximately 30.0 million gross proceeds. 